Windtree Therapeutics Current Ratio 2006-2021 | WINT

Windtree Therapeutics current ratio from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Windtree Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.03B $0.01B 6.58
2021-03-31 $0.04B $0.01B 5.26
2020-12-31 $0.02B $0.01B 2.96
2020-09-30 $0.02B $0.01B 3.81
2020-06-30 $0.03B $0.01B 2.75
2020-03-31 $0.02B $0.01B 2.61
2019-12-31 $0.02B $0.01B 3.05
2019-09-30 $0.01B $0.02B 0.32
2019-06-30 $0.01B $0.02B 0.64
2019-03-31 $0.02B $0.02B 0.95
2018-12-31 $0.03B $0.02B 1.24
2018-09-30 $0.00B $0.02B 0.06
2018-06-30 $0.00B $0.02B 0.07
2018-03-31 $0.00B $0.02B 0.13
2017-12-31 $0.00B $0.01B 0.19
2017-09-30 $0.00B $0.03B 0.11
2017-06-30 $0.00B $0.03B 0.16
2017-03-31 $0.01B $0.03B 0.38
2016-12-31 $0.01B $0.01B 0.54
2016-09-30 $0.01B $0.01B 0.97
2016-06-30 $0.02B $0.02B 1.46
2016-03-31 $0.03B $0.02B 2.14
2015-12-31 $0.04B $0.01B 3.69
2015-09-30 $0.05B $0.01B 4.98
2015-06-30 $0.03B $0.01B 2.73
2015-03-31 $0.04B $0.01B 3.91
2014-12-31 $0.05B $0.01B 5.82
2014-09-30 $0.06B $0.01B 5.91
2014-06-30 $0.07B $0.01B 6.12
2014-03-31 $0.08B $0.01B 6.90
2013-12-31 $0.09B $0.01B 7.36
2013-09-30 $0.02B $0.01B 1.92
2013-06-30 $0.03B $0.01B 3.08
2013-03-31 $0.03B $0.01B 2.07
2012-12-31 $0.03B $0.01B 2.38
2012-09-30 $0.04B $0.02B 2.36
2012-06-30 $0.05B $0.01B 3.69
2012-03-31 $0.06B $0.02B 3.78
2011-12-31 $0.01B $0.01B 0.95
2011-09-30 $0.02B $0.01B 1.21
2011-06-30 $0.02B $0.02B 1.45
2011-03-31 $0.03B $0.01B 2.02
2010-12-31 $0.01B $0.01B 1.39
2010-09-30 $0.02B $0.01B 1.81
2010-06-30 $0.02B $0.01B 2.54
2010-03-31 $0.02B $0.02B 1.56
2009-12-31 $0.02B $0.02B 0.84
2009-09-30 $0.02B $0.02B 1.06
2009-06-30 $0.02B $0.02B 1.35
2009-03-31 $0.02B $0.01B 2.20
2008-12-31 $0.03B $0.01B 2.58
2008-09-30 $0.03B $0.01B 2.81
2008-06-30 $0.04B $0.01B 3.31
2008-03-31 $0.04B $0.01B 4.72
2007-12-31 $0.05B $0.01B 5.12
2007-09-30 $0.03B $0.01B 3.72
2007-06-30 $0.04B $0.01B 5.23
2007-03-31 $0.02B $0.01B 2.96
2006-12-31 $0.03B $0.01B 3.38
2006-09-30 $0.02B $0.02B 1.16
2006-06-30 $0.03B $0.02B 1.57
2006-03-31 $0.04B $0.02B 2.10
2005-12-31 $0.05B $0.02B 2.92
2005-09-30 $0.05B $0.01B 6.48
2005-06-30 $0.04B $0.01B 5.68
2005-03-31 $0.05B $0.01B 7.41
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.050B $0.000B
Windtree Therapeutics, Inc. is a biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. The company's proprietary technology platform includes a synthetic, peptide-containing surfactant that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree Therapeutics, Inc., formerly known as Discovery Laboratories Inc., is based in Warrington, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76